Miscellaneous

Thank you for your interest in our webinar on the dual role of mast cells, titled "Mast Cells: Can't live with them, can't live without them?". Below, you will find the questions we did not have time to address during the live session with Dr. Marcus Maurer. Q: In cold activated urticaria, is some of it caused by clonotypic IgE whichRead more

Top-level science through the eyes of an expert.The second Webinar. The second webinar in the Naked Immunology series took place on May 10, 2022 at 8 a.m. (PST), 11 a.m. (EST), 5 p.m. (CET). The webinar is open to English-speaking participants with a solid scientific background. Featured speaker is Highly Cited Researcher and immunology expert, Dr. Florent Ginhoux. watch theRead more

Top-level science through the eyes of an expert.The first Webinar. The first webinar in the Naked Immunology series took place on March 9, 2022 at 5:00 PM (CET) - 11 AM (EST) and is open to English-speaking participants with a solid scientific background. Featured speaker is globally renowned immunology expert Dr. Nicolas Gaudenzio. watch the replay Mast cells are tissue-residentRead more

Genoskin awarded the Healthtech prize “Transformons la France!” Yesterday, Genoskin was awarded the Healthtech prize at the “Transformons la France!” (Let’s Transform France!) ceremony presented by La Tribune in Toulouse. While the current health crisis calls into question our lifestyles, "Transformons la France!" highlights the talents of tomorrow and gives impact to those who transform society for the better. TheRead more

Genoskin in the News: article on Benzinga Benzinga biotech reporter Shanthi Rexaline recently spoke to GENOSKIN's CEO Pascal Descargues. In the interview, Pascal shared the inspiration behind founding Genoskin: Pascal quickly realized during his postdoctoral fellowship that animal models were not predictive enough. Pascal also had the opportunity to present Genoskin’s technology. He walked Shanthi through the Genoskin workflow: from sourcingRead more

Genoskin featured in a Business Insider article The press is talking about Genoskin! Amid COVID-19 breakout, Genoskin got attention from Business Insider 's reporter Mia Jankowicz.  We recently communicated on our continued efforts during the pandemic and our preferred access program for research on COVID-19. Genoskin's projects and technology caught the eye of Mia Jankowicz. Mia, a journalist specializing inRead more